top of page


Our Services:
  • Diagnosis of Adult and Pediatric Movement and Neurodegenerative Disorders

  • Injections of Botulinum Toxins (Botox, Xeomin, Myobloc)

  • Neurogenetics

  • Deep Brain Stimulation

  • Neuravive, MR-guided focused ultrasound treatment for refractory essential tremor

  • EMG

  • Clinical Research Trials

  • Huntington Disease Center of Excellence

  • Telemedicine (

Where To Find Us >
Latest Clinic News:
  • Several new clinical trials for patients with Parkinson's disease (Cerevel, Inhibikinase, Annovis, UCB Pharma, Intracellular Therapies, Sage, and Scion NeuroStim) are open to enrollment

  • Aeon Study of ABP-450 (prabotulinumtoxinA) Injection for the Treatment of Cervical Dystonia - completed

  • Cerevel Study to Evaluate the Efficacy, Safety and Tolerability of Tavapadon in Early Parkinson's Disease (TEMPO-2 TRIAL) - open to enrollment

  • Cerevel Study to Evaluate the Efficacy, Safety and Tolerability of Tavapadon as Adjunctive Therapy for Parkinson's Disease in Levodopa-Treated Adults with Motor Fluctuations (TEMPO-3 TRIAL) - enrollment completed

  • Pharma2B Study of Parkinson Disease - enrollment complete.  Positive safety and efficacy data of P2B001 presented at the MDS International Congress of Parkinson' Disease and Movement Disorders.

  • NILO-PD Study of Parkinson Disease - Results published in JAMA Neurol (2021;78:312-320)

  • Dystonia Coalition - Renewed for 5 years by the National Institutes of Health

  • Revance ASPEN-OLS Study of Cervical Dystonia - completed

  • Myobloc - FDA Approved for Troublesome Sialorrhea (Drooling).  Results published in JAMA Neurol (2020;77:461-469).


Botulinum toxins

Botox - Xeomin - Myobloc
bottom of page